Zurich Cantonal Bank’s BeOne Medicines Ltd ONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-3,087
Closed -$1.01M 3474
2025
Q3
$1.05M Buy
+3,087
New +$937K ﹤0.01% 1257
2024
Q1
Sell
-60
Closed -$10.8K 2737
2023
Q4
$10.8K Sell
60
-7
-10% -$1.27K ﹤0.01% 2675
2023
Q3
$12.1K Sell
67
-22
-25% -$4.35K ﹤0.01% 2731
2023
Q2
$15.9K Sell
89
-27
-23% -$6.22K ﹤0.01% 2731
2023
Q1
$25K Buy
+116
New +$27.8K ﹤0.01% 2725
2022
Q4
Sell
-24,324
Closed -$3.28M 2915
2022
Q3
$3.28M Buy
24,324
+1,307
+6% +$224K 0.02% 561
2022
Q2
$3.73M Buy
23,017
+2,073
+10% +$324K 0.02% 541
2022
Q1
$3.95M Buy
20,944
+3,948
+23% +$839K 0.02% 568
2021
Q4
$4.61M Buy
16,996
+1,188
+8% +$401K 0.02% 550
2021
Q3
$5.74M Buy
15,808
+373
+2% +$122K 0.03% 472
2021
Q2
$5.3M Sell
15,435
-3,041
-16% -$1.01M 0.03% 476
2021
Q1
$6.43M Buy
18,476
+6,539
+55% +$2.17M 0.04% 415
2020
Q4
$3.08M Sell
11,937
-1,854
-13% -$510K 0.02% 622
2020
Q3
$3.95M Buy
13,791
+2,394
+21% +$563K 0.03% 493
2020
Q2
$2.15M Sell
11,397
-82
-0.7% -$13.3K 0.02% 620
2020
Q1
$1.41M Buy
11,479
+1,140
+11% +$178K 0.01% 666
2019
Q4
$1.71M Buy
10,339
+873
+9% +$145K 0.01% 707
2019
Q3
$1.16M Buy
9,466
+1,161
+14% +$154K 0.01% 775
2019
Q2
$1.03M Buy
8,305
+962
+13% +$122K 0.01% 797
2019
Q1
$969K Hold
7,343
0.01% 792
2018
Q4
$1.03M Buy
+7,343
New +$974K 0.01% 742

Other funds holding ONC

Zurich Cantonal Bank's ONC Position: Q4 2025 in Review

Zurich Cantonal Bank sold out of BeOne Medicines Ltd (ONC) in Q4 2025, closing a stake of 3,087 shares — an estimated $1.01M sold.

Zurich Cantonal Bank first reported a position in ONC in Q4 2018 and held it in 21 quarters. The position peaked at $6.43M in Q1 2021. 286 funds tracked by Wall St. Rank hold ONC as of Q4 2025.

  • Zurich Cantonal Bank reported no remaining BeOne Medicines Ltd position as of Q4 2025 after selling out during the quarter.
  • Zurich Cantonal Bank sold 3,087 BeOne Medicines Ltd shares in Q4 2025, an estimated $1.01M.
  • Zurich Cantonal Bank first reported a position in BeOne Medicines Ltd in Q4 2018 and held it in 21 quarters.
  • Zurich Cantonal Bank's BeOne Medicines Ltd position peaked at $6.43M in Q1 2021.
  • 286 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2025.

Based on Zurich Cantonal Bank's 13F filing for Q4 2025, filed 27 Jan 2026.